Publications (69) Carlos Spuch Calvar publications

2024

  1. An Injectable Composite Co-Assembled Dehydropeptide-Based Magnetic/Plasmonic Lipogel for Multimodal Cancer Therapy

    Advanced Functional Materials

  2. Glucagon-like peptide 1 receptor activation: anti-inflammatory effects in the brain

    Neural Regeneration Research, Vol. 19, Núm. 8, pp. 1617-1677

  3. Longitudinal changes in the functional connectivity of individuals at risk of Alzheimer’s disease

    GeroScience, Vol. 46, Núm. 3, pp. 2989-3003

2023

  1. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions

    Psychiatry Research, Vol. 330

  2. Human Breast Milk microRNAs, Potential Players in the Regulation of Nervous System

    Nutrients, Vol. 15, Núm. 14

  3. Proteomic analysis of exosomes derived from human mature milk and colostrum of mothers with term, late preterm, or very preterm delivery

    Analytical Methods, Vol. 15, Núm. 37, pp. 4905-4917

2022

  1. Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases

    International journal of molecular sciences, Vol. 23, Núm. 17

  2. Changes in the Brain Extracellular Matrix Composition in schizophrenia: A Pathophysiological Dysregulation and a Potential Therapeutic Target

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 6, pp. 1921-1932

  3. Efficacy and Safety of Lithium Treatment in SARS-CoV-2 Infected Patients

    Frontiers in Pharmacology, Vol. 13

  4. Efficacy of the Therapeutic Game “Trisquel” in the Treatment of Patients With Substance-Related Disorders Randomized Clinical Study

    Frontiers in Psychiatry, Vol. 13

  5. New Trends in Cognitive Aging and Mild Cognitive Impairment

    Geriatrics (Switzerland)

  6. Tuning the drug multimodal release through a co-assembly strategy based on magnetic gels

    Nanoscale, Vol. 14, Núm. 14, pp. 5488-5500

2021

  1. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis

    Annals of Medicine, Vol. 53, Núm. 1, pp. 43-69

  2. Proteomic and metabolic profiling of chronic patients with schizophrenia induced by a physical activity program: Pilot study

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 125-138

  3. The role of the second extracellular loop of norepinephrine transporter, neurotrophin-3 and tropomyosin receptor kinase C in T cells: A peripheral biomarker in the etiology of schizophrenia

    International Journal of Molecular Sciences, Vol. 22, Núm. 16

  4. Voices 2: Improving Prosodic Recognition in Schizophrenia With an Online Rehabilitation Program

    Frontiers in Psychology, Vol. 12

2020

  1. A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine

    Frontiers in Psychiatry, Vol. 11

  2. Annexin A5 prevents amyloid-β-induced toxicity in choroid plexus: implication for Alzheimer’s disease

    Scientific Reports, Vol. 10, Núm. 1

  3. Brainwaves Oscillations as a Potential Biomarker for Major Depression Disorder Risk

    Clinical EEG and Neuroscience, Vol. 51, Núm. 1, pp. 3-9

  4. Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report

    Frontiers in Pharmacology, Vol. 11